Hypera S.A. (HYPMY)
PNK: HYPMY
· Real-Time Price · USD
3.71
-0.19 (-4.87%)
At close: May 01, 2025, 2:19 PM
-4.87% (1D)
| Bid | 3.71 |
| Market Cap | 2.34B |
| Revenue (ttm) | 6.7B |
| Net Income (ttm) | 808.8M |
| EPS (ttm) | 0.23 |
| PE Ratio (ttm) | 16.13 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 4.26 |
| Volume | 5 |
| Avg. Volume (20D) | 6,245 |
| Open | 3.90 |
| Previous Close | 3.90 |
| Day's Range | 3.71 - 3.90 |
| 52-Week Range | 2.64 - 6.02 |
| Beta | 0.34 |
About HYPMY
Hypera S.A. operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, MaxSulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal...
Sector Healthcare
IPO Date Oct 15, 2010
Employees 10,481
Stock Exchange PNK
Ticker Symbol HYPMY
Website https://www.hyperapharma.com.br
